ONKURE THERAPEUTICS, INC. (OKUR)

SEC filing

ONKURE THERAPEUTICS, INC.

OKUR · CIK 1637715

4 · Sep 23, 2026 · Chief Financial Officer Leverone Jason A. sold 302 Class A Common Stock at $2.97/unit ($898)

Chief Financial Officer Leverone Jason A. sold 302 Class A Common Stock at $2.97/unit ($898)

xslF345X06/form4-09232026_080937.xml

xslF345X06/form4-09232026_080937.xmlSEC.gov

Graphics and non-inline formats (not embedded below).